CUSIP: M87245102
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
24,737,049
-
Share change
-
-721,425
-
Total reported value
-
$180,820,980
-
Price per share
-
$7.31
-
Number of holders
-
56
-
Value change
-
-$5,282,460
-
Number of buys
-
18
-
Number of sells
-
25
Quarterly Holders Quick Answers
What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP M87245102:
Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q1 2016
As of 31 Mar 2016,
SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,737,049 shares.
The largest 10 holders included
Senvest Management, LLC, NORTH TIDE CAPITAL, LLC, JPMORGAN CHASE & CO, BRANDES INVESTMENT PARTNERS, LP, DALTON GREINER HARTMAN MAHER & CO, Camber Capital Management LLC, SENZAR ASSET MANAGEMENT, LLC, Ion Asset Management Ltd., RENAISSANCE TECHNOLOGIES LLC, and Broadfin Capital, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.